Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Work
Year: 2018
Type: article
Abstract: Cabozantinib inhibits tyrosine kinases, including vascular endothelial growth factor receptors 1, 2, and 3, MET, and AXL, which are implicated in the progression of hepatocellular carcinoma and the de... more
Source: New England Journal of Medicine
Authors Ghassan K. Abou‐Alfa, Tim Meyer, Ann‐Lii Cheng, Anthony B. El-Khoueiry, Lorenza Rimassa +17 more
Institutions Cornell University, Memorial Sloan Kettering Cancer Center, University College London, The Royal Free Hospital, National Taiwan University Hospital +16 more
Cites: 31
Cited by: 1,982
Related to: 10
FWCI: 158.1
Citation percentile (by year/subfield): 99.98
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze
Funder Exelixis